GSK beats first-quarter profit, revenue estimates GSK has today beaten expectations for its first-quarter revenue and profit, helped by sales of its blockbuster shingles vaccine Shingrix. Business • 26 Apr 23
GSK beats first-quarter profit, revenue estimates GSK has today beaten expectations for its first-quarter revenue and profit, helped by sales of its blockbuster shingles vaccine Shingrix. Business • 26 Apr 23
